Diminished thrombogenic responses by deletion of the Podocalyxin gene in mouse megakaryocytes

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Pericacho, Miguel ^b   Alonso Martín, Sonia ^a   Larrucea, Susana ^c   González Manchón, Consuelo ^a,b   Fernández, Darío ^b   Sánchez, Inés ^a   Ayuso, Matilde S ^a,b   Parrilla, Roberto ^a,b  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FERRIC CHLORIDE; PHENYLEPHRINE; PODOCALYXIN; CHLORIDE; FERRIC ION; SIALOGLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; CAROTID ARTERY; CONTROLLED STUDY; GENE DELETION; GENE TARGETING; GROWTH RATE; IN VITRO STUDY; KIDNEY CELL; LIFESPAN; MEGAKARYOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PODOCYTE; PODXL GENE; POLYPLOIDY; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOGENICITY; THROMBOSIS; ANIMAL; BLEEDING; BLOOD CLOTTING; C57BL MOUSE; CELL COUNT; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE ADHESIVENESS;

MUS;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; CAROTID ARTERIES; CELL COUNT; CHLORIDES; FERRIC COMPOUNDS; GENE DELETION; HEMORRHAGE; MEGAKARYOCYTES; MICE; MICE, INBRED C57BL; PLATELET ADHESIVENESS; PLATELET AGGREGATION; SIALOGLYCOPROTEINS; THROMBOSIS;

EID: 80053901562     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026025     Document Type: Article

References (40)

1. Furness SG, McNagny K, (2006) Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis. Immunol Res 34: 13-32.
2. Kerjaschki D, Sharkey DJ, Farquhar MG, (1984) Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98: 1591-1596.
3. Somlo S, Mundel P, (2000) Getting a foothold in nephrotic syndrome. Nat Genet 24: 333-335.
4. Endlich K, Kriz W, Witzgall R, (2001) Update in podocyte biology. Curr Opin Nephrol Hypertens 10: 331-340.
5. Eddy A, Schnaper H, (1998) The nephrotic syndrome: From the simple to the complex. Semin Nephrol 18: 12.
6. Mundel P, Shankland SJ, (2002) Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015.
7. Doyonnas R, Nielsen JS, Chelliah S, Drew E, Hara T, et al. (2005) Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells. Blood 105: 4170-4178.
8. Horvat R, Hovorka A, Dekan G, Poczewski H, Kerjaschki D, (1986) Endothelial cell membranes contain podocalyxin-the major sialoprotein of visceral glomerular epithelial cells. J Cell Biol 102: 484-491.
9. Kerosuo L, Juvonen E, Alitalo R, Gylling M, Kerjaschki D, et al. (2004) Podocalyxin in human haematopoietic cells. Br J Haematol 124: 809-818.
10. McNagny KM, Pettersson I, Rossi F, Flamme I, Shevchenko A, et al. (1997) Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors. J Cell Biol 138: 1395-1407.
11. Schopperle WM, Kershaw DB, DeWolf WC, (2003) Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin. Biochem Biophys Res Commun 300: 285-290.
12. Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, et al. (2004) Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res 64: 5068-5073.
13. Casey G, Neville PJ, Liu X, Plummer SJ, Cicek MS, et al. (2006) Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. Hum Mol Genet 15: 735-741.
14. Miettinen A, Solin ML, Reivinen J, Juvonen E, Vaisanen R, et al. (1999) Podocalyxin in rat platelets and megakaryocytes. Am J Pathol 154: 813-822.
15. Alexander WS, Viney EM, Zhang JG, Metcalf D, Kauppi M, et al. (2006) Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene. Proc Natl Acad Sci U S A 103: 16442-16447.
16. Larrucea S, Butta N, Arias-Salgado EG, Alonso-Martin S, Ayuso MS, et al. (2008) Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells. Exp Cell Res 314: 2004-2015.
17. Baumheter S, Singer MS, Henzel W, Hemmerich S, Renz M, et al. (1993) Binding of L-selectin to the vascular sialomucin CD34. Science 262: 436-438.
18. Sassetti C, Tangemann K, Singer MS, Kershaw DB, Rosen SD, (1998) Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34. J Exp Med 187: 1965-1975.
19. Paavonen T, Renkonen R, (1992) Selective expression of sialyl-Lewis x and Lewis a epitopes, putative ligands for L-selectin, on peripheral lymph-node high endothelial venules. Am J Pathol 141: 1259-1264.
20. Jiang M, Spicher K, Boulay G, Martin-Requero A, Dye CA, et al. (2002) Mouse gene knockout and knockin strategies in application to alpha subunits of Gi/Go family of G proteins. Methods Enzymol 344: 277-298.
21. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC, (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 90: 8424-8428.
22. Torres M, (1998) The use of embryonic stem cells for the genetic manipulation of the mouse. Curr Top Dev Biol 36: 99-114.
23. Tiedt R, Schomber T, Hao-Shen H, Skoda RC, (2007) Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood 109: 1503-1506.
24. Rasband WS, ImageJ. Available: http://rsb.info.nih.gov/ij/. U S National Institutes of Health, Bethesda, Maryland, USA: 1997-2009.
25. Rodriguez RB, Butta N, Larrucea S, Alonso S, Parrilla R, (2006) Production and characterization of murine monoclonal antibodies against human podocalyxin. Tissue Antigens 68: 407-417.
26. Larrucea S, Butta N, Rodriguez RB, Alonso-Martin S, Arias-Salgado EG, et al. (2007) Podocalyxin enhances the adherence of cells to platelets. Cell Mol Life Sci 64: 2965-2974.
27. Alonso-Martin S, Nowakowski A, Larrucea S, Fernandez D, Vilar-Egea M, et al. Overexpression of podocalyxin in megakaryocytes and platelets decreases the bleeding time and enhances the agonist-induced aggregation of platelets. Thromb Res 125: e300-305.
28. Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, et al. (2000) Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 106: 385-392.
29. Bergmeier W, Piffath CL, Goerge T, Cifuni SM, Ruggeri ZM, et al. (2006) The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci U S A 103: 16900-16905.
30. Ni H, Yuen PS, Papalia JM, Trevithick JE, Sakai T, et al. (2003) Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci U S A 100: 2415-2419.
31. Yang H, Reheman A, Chen P, Zhu G, Hynes RO, et al. (2006) Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. J Thromb Haemost 4: 2230-2237.
32. Liu S, Calderwood DA, Ginsberg MH, (2000) Integrin cytoplasmic domain-binding proteins. J Cell Sci 113 (Pt 20): 3563-3571.
33. Grottum KA, Solum NO, (1969) Congenital thrombocytopenia with giant platelets: a defect in the platelet membrane. Br J Haematol 16: 277-290.
34. Mester L, Szabados L, Born GV, Michal F, (1972) Changes in the aggregation of platelets enriched in sialic acid. Nat New Biol 236: 213-214.
35. Li J, Li Y, Brophy PD, Kershawt DB, (2001) Gene structure and alternative splicing of murine podocalyxin: a member of the CD34 sialomucin family. DNA Seq 12: 407-412.
36. Burridge K, Chrzanowska-Wodnicka M, (1996) Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12: 463-518.
37. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, et al. (1999) The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 274: 28071-28074.
38. Tadokoro S, Shattil SJ, Eto K, Tai V, Liddington RC, et al. (2003) Talin binding to integrin beta tails: a final common step in integrin activation. Science 302: 103-106.
39. Burridge K, Mangeat P, (1984) An interaction between vinculin and talin. Nature 308: 744-746.
40. Hemmings L, Rees DJ, Ohanian V, Bolton SJ, Gilmore AP, et al. (1996) Talin contains three actin-binding sites each of which is adjacent to a vinculin-binding site. J Cell Sci 109 (Pt 11): 2715-2726.